Comparison of the effect of triamcinolone and dexmedetomidine injections in the treatment of heel pai

Phase 2

Recruiting

Conditions: Chronic heel pain and plantar fasciitis.
Plantar fascial fibromatosis
M72.2

Registration Number: IRCT20170423033615N2

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Age 18 and above
Patients with initial complaint of heel pain after weight bearing after a period of rest
Heel pain and plantar fasciitis for more than three months
Patients with unilateral chronic plantar fasciitis
Failure to respond to conservative treatments
Pain that goes away after a few minutes of walking but returns after prolonged walking or standing
Pain caused by palpation of medial calcaneal tuberosity, dorsiflexion of the foot passively
Chronic heel pain of three months or more without evidence of acute trauma to the heel
VAS > 5 after taking the first step following rest
Patients with satisfaction to participate in the study

Exclusion Criteria

Mechanical pains in the posterior part of the heel in the form of Achilles tendonitis/bursitis
Neurological heel pain caused by nerve rupture
Heel arthritis pain
Traumatic heel pain
Bilateral plantar fasciitis
Heel pain for more than three months
Skin ulcer around the heel and treatment of that area
Sciatica pain; benign and malignant tumors; acute infection; diabetes; sensory neuropathy; peripheral vascular disease / autoimmune disease; fibromyalgia; chronic fatigue syndrome
Light sensitivity disorder
Pregnancy and breastfeeding

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain level. Timepoint: Before starting treatment, 4 and 12 weeks after injection. Method of measurement: Visual analog scale (VAS) (0 None; 1-3 Mild; 4-7 Moderate; 8-10 Severe).

Secondary Outcome Measures